BioGaia investor relations material

BioGaia AB develops and markets a wide range of probiotic products with documented health benefits. The company is focused on human health, animal health and the environment, and creates new benefits through the development of novel target groups and or applications. The company's current product portfolio includes Dysbiosis Treatment, Concept 2, Gastrointestinal Fortifier, Protectis, Nestum, Synbiome Defense, and Vi-sualize. Its products are used in various applications such as food supplement industry, animal health sector and human health sector.